Volume 12, Issue 1 (11-2022)                   aumj 2022, 12(1): 1-6 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Haghi S, Arjmand R, Gholami M. A Case Report of Hodgkin's lymphoma with Early Manifestation of Henoch-Schonlein Purpura in a Child. aumj 2022; 12 (1) :1-6
URL: http://aums.abzums.ac.ir/article-1-1617-en.html
1- Assistant Professor of Pediatric Hematology and Oncology, Department of Pediatrics, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
2- Assistant Professor of Pediatric Infectious Disease, Department of Pediatrics, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
3- Clinical Research Development Unit of Imam Ali Hospital, Alborz University of Medical Sciences, karaj, Iran
Abstract:   (1247 Views)
Hodgkin's lymphoma is one of the most common types of lymphoma among children, usually characterized by persistent head and neck adenopathies that are unresponsive to antibiotic treatment. In rare cases, the primary manifestation of this malignancy includes paraneoplastic, immunological, and vasculitic syndromes in children. Here, we introduce a 13-year-old boy, and Hodgkin's lymphoma was initially manifested as Henoch-Schonlein purpura and eventually led to his hospitalization.
 
Full-Text [PDF 271 kb]   (781 Downloads)    
Type of Study: Research | Subject: Special
Received: 2022/10/23 | Accepted: 2022/08/01 | Published: 2022/08/01

References
1. Get persistent links for your reference list or bibliography. Copy and paste the list, we’ll match with our metadata and return the links. Members may also deposit reference lists here too. Saulsbury, F.T., Henoch-Schönlein purpura. Current opinion in rheumatology, 2010. 22(5): p. 598-602. [DOI:10.1097/BOR.0b013e32833af608]
2. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002 Oct 19;360(9341):1197-202. [DOI:10.1016/S0140-6736(02)11279-7]
3. Trapani S, Micheli A, Grisolia F, Resti M, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum. 2005 Dec;35(3):143-53. [DOI:10.1016/j.semarthrit.2005.08.007]
4. Harrison, T.R., et al., Principles of internal medicine. Academic Medicine, 1962. 37(11): p. 1246.
5. Sherief LM, Elsafy UR, Abdelkhalek ER, Kamal NM, et al. Hodgkin lymphoma in childhood: clinicopathological features and therapy outcome at 2 centers from a developing country. Medicine (Baltimore). 2015 Apr;94(15):e670. [DOI:10.1097/MD.0000000000000670]
6. Hartmann S, Goncharova O, Portyanko A, Sabattini E, et al. CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma. Mod Pathol. 2019 Jan;32(1):37-47. [DOI:10.1038/s41379-018-0108-5]
7. Castellino SM, Geiger AM, Mertens AC, Leisenring WM, et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood. 2011 Feb 10;117(6):1806-16. [DOI:10.1182/blood-2010-04-278796]
8. Girinsky T, van der Maazen R, Specht L, Aleman B, et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother Oncol. 2006 Jun;79(3):270-7. [DOI:10.1016/j.radonc.2006.05.015]
9. Biggi A, Gallamini A, Chauvie S, Hutchings M, et al. International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nucl Med. 2013 May;54(5):683-90. [DOI:10.2967/jnumed.112.110890]
10. Devita VT Jr, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med. 1970 Dec;73(6):881-95. [DOI:10.7326/0003-4819-73-6-881]
11. Donaldson SS, Link MP, Weinstein HJ, Rai SN, et al. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol. 2007 Jan 20;25(3):332-7. [DOI:10.1200/JCO.2006.08.4772]
12. Punnett A, Tsang RW, Hodgson DC. Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects. Semin Radiat Oncol. 2010 Jan;20(1):30-44. [DOI:10.1016/j.semradonc.2009.09.006]
13. Winterbauer RH, Belic N, Moores KD. Clinical interpretation of bilateral hilar adenopathy. Ann Intern Med. 1973 Jan;78(1):65-71. [DOI:10.7326/0003-4819-78-1-65]
14. Baez F, Ocampo E, Conter V, Flores A, et al. Treatment of childhood Hodgkin's disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua. Ann Oncol. 1997 Mar;8(3):247-50. [DOI:10.1023/A:1008200210674]
15. Gottlieb,A.J.Allergicpurpura.In:Williams,W.J.,Beutler,E.,Ersley,A.&Lichman,M.A.(eds)Haematology,3rdEdition,McGraw-Hill,NewYork,1986,pp.1371-1377.
16. Mitchell DM, Hoffbrand BI. Relapse of Henoch-Schönlein disease associated with lung carcinoma. J R Soc Med. 1979 Aug;72(8):614-5. [DOI:10.1177/014107687907200814]
17. Maurice,T.R. Carcinoma of bronchus presenting with Henoch-Schönlein purpura. Br Med J. 1978 Sep 16;2(6140):831. [DOI:10.1136/bmj.2.6140.831-c]
18. Arpels C, Southam CM. Cytotoxicity of sera from healthy persons and cancer patients. Int J Cancer. 1969 Jul 15;4(4):548-59. [DOI:10.1002/ijc.2910040419]
19. Costanza ME, Pinn V, Schwartz RS, Nathanson L. Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N Engl J Med. 1973 Sep 6;289(10):520-2. [DOI:10.1056/NEJM197309062891007]
20. Jean-Pierre Ng, John M, E.M. Chalmers, R.B. Hogg, et al.'Henoch-Schonlein purpura and Hodgkin's disease .Postgraduate Medical Journal (1988) 64, 881-882. [DOI:10.1136/pgmj.64.757.881]
21. Bian Y, Oropesa S, Idowu OO, Kudose S, Husain S, Bhagat G, Winn BJ. Henoch-Schönlein Purpura Associated With Diffuse Large B-cell Lymphoma of the Orbit. Ophthalmic Plast Reconstr Surg. 2021 Mar-Apr 01;37(2):e47-e50. [DOI:10.1097/IOP.0000000000001739]

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Alborz University Medical Journal

Designed & Developed by : Yektaweb